616 related articles for article (PubMed ID: 7975249)
1. Susceptibility and resistance to Moloney murine leukemia virus-induced promonocytic leukemia.
Nazarov V; Hilbert D; Wolff L
Virology; 1994 Dec; 205(2):479-85. PubMed ID: 7975249
[TBL] [Abstract][Full Text] [Related]
2. Effect of non-H-2-linked genes on anti-virus immune responses and long-term survival in mice persistently infected with E-55+ murine leukemia virus.
Avidan N; Tumas-Brundage KM; Sieck TG; Prystowsky MB; Blank KJ
Virology; 1995 Aug; 211(2):507-15. PubMed ID: 7645254
[TBL] [Abstract][Full Text] [Related]
3. Mml1, a new common integration site in murine leukemia virus-induced promonocytic leukemias maps to mouse chromosome 10.
Koller R; Krall M; Mock B; Bies J; Nazarov V; Wolff L
Virology; 1996 Oct; 224(1):224-34. PubMed ID: 8862417
[TBL] [Abstract][Full Text] [Related]
4. A chronic inflammatory response. Its role in supporting the development of c-myb and c-myc related promonocytic and monocytic tumors in BALB/c mice.
Wolff L; Mushinski JF; Shen-Ong GL; Morse HC
J Immunol; 1988 Jul; 141(2):681-9. PubMed ID: 2838552
[TBL] [Abstract][Full Text] [Related]
5. Phenotyping of Evi1, Evi11/Cb2, and Evi12 transformed leukemias isolated from a novel panel of cas-Br-M murine leukemia virus-infected mice.
Joosten M; Valk PJ; Vankan Y; de Both N; Löwenberg B; Delwel R
Virology; 2000 Mar; 268(2):308-18. PubMed ID: 10704339
[TBL] [Abstract][Full Text] [Related]
6. Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia.
Nason-Burchenal K; Wolff L
Proc Natl Acad Sci U S A; 1993 Feb; 90(4):1619-23. PubMed ID: 7679511
[TBL] [Abstract][Full Text] [Related]
7. Differential behavior of the Mo + PyF101 enhancer variant of Moloney murine leukemia virus in rats and mice.
Brightman BK; Okimoto M; Kulkarni V; Lander JK; Fan H
Virology; 1998 Mar; 242(1):60-7. PubMed ID: 9501051
[TBL] [Abstract][Full Text] [Related]
8. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens.
Ng AK; Ames RS; McIntire RK; Herberman RB
Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation from Fv-4-resistant donors rescues Friend leukemia virus-infected mice from leukemia: a model of bone marrow transplantation therapy against retroviral infection.
Kitagawa M; Kamisaku H; Aizawa S; Sado T
Leukemia; 1994 Dec; 8(12):2200-6. PubMed ID: 7808008
[TBL] [Abstract][Full Text] [Related]
10. A model for mixed virus disease: co-infection with Moloney murine leukemia virus potentiates runting induced by polyomavirus (A2 strain) in Balb/c and NIH Swiss mice.
Atencio IA; Belli B; Hobbs M; Cheng SF; Villarreal LP; Fan H
Virology; 1995 Oct; 212(2):356-66. PubMed ID: 7571405
[TBL] [Abstract][Full Text] [Related]
11. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice.
Panoutsakopoulou V; Little CS; Sieck TG; Blankenhorn EP; Blank KJ
J Immunol; 1998 Jul; 161(1):17-26. PubMed ID: 9647202
[TBL] [Abstract][Full Text] [Related]
12. Anti-Gag cytolytic T lymphocytes specific for an alternative translational reading frame-derived epitope and resistance versus susceptibility to retrovirus-induced murine AIDS in F(1) mice.
Mayrand SM; Healy PA; Torbett BE; Green WR
Virology; 2000 Jul; 272(2):438-49. PubMed ID: 10873788
[TBL] [Abstract][Full Text] [Related]
13. Distribution of Fv-4 resistant gene product in Friend leukemia virus-resistant Fv-4r mouse strain.
Kitagawa M; Aizawa S; Kamisaku H; Sado T; Ikeda H; Hirokawa K
Exp Hematol; 1996 Oct; 24(12):1423-31. PubMed ID: 8913289
[TBL] [Abstract][Full Text] [Related]
14. Genetic control of sensitivity to Moloney leukemia virus in mice. III. The three H-2 linked Rmv genes are immune response genes controlling the antiviral antibody response.
Debré P; Boyer B; Gisselbrecht S; Bismuth A; Lévy JP
Eur J Immunol; 1980 Dec; 10(12):914-8. PubMed ID: 6781910
[TBL] [Abstract][Full Text] [Related]
15. Incidence and phenotypic heterogeneity of Moloney virus-induced leukemias: a multigenic control.
Debre P; Gisselbrecht S; Boyer B; Levy JP
Blood Cells; 1981; 7(2):301-11. PubMed ID: 6975141
[TBL] [Abstract][Full Text] [Related]
16. Flow-microfluorometric monitoring of oligoclonal CD8+ T cell responses to an immunodominant Moloney leukemia virus-encoded epitope in vivo.
Brawand P; Biasi G; Horvath C; Cerottini JC; MacDonald HR
J Immunol; 1998 Feb; 160(4):1659-65. PubMed ID: 9469422
[TBL] [Abstract][Full Text] [Related]
17. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
Reif AE
Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
[TBL] [Abstract][Full Text] [Related]
18. 10A1 MuLV induces a murine leukemia that expresses hematopoietic stem cell markers by a mechanism that includes fli-1 integration.
Ott DE; Keller J; Rein A
Virology; 1994 Dec; 205(2):563-8. PubMed ID: 7975258
[TBL] [Abstract][Full Text] [Related]
19. T lymphocyte tolerance and early appearance of virus-induced cell surface antigens in Moloney-murine leukemia virus neonatally injected mice.
Collavo D; Zanovello P; Biasi G; Chieco-Bianchi L
J Immunol; 1981 Jan; 126(1):187-93. PubMed ID: 6969741
[TBL] [Abstract][Full Text] [Related]
20. Involvement of the spleen in preleukemic development of a murine retrovirus-induced promonocytic leukemia.
Nason-Burchenal K; Wolff L
Cancer Res; 1992 Oct; 52(19):5317-22. PubMed ID: 1394137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]